A new gene therapy is giving people born deaf the chance to hear, often within just weeks. In a small but groundbreaking ...

This gene therapy regimen seems to be working wonders.

A groundbreaking gene therapy trial has successfully restored hearing in individuals with a rare form of congenital deafness.

Eli Lilly and Regeneron are leading the push to treat congenital deafness with gene therapies, seeking a piece of a potential ...

A single jab of a breakthrough gene therapy could reverse hearing loss in people within weeks, according to new research. The cutting-edge therapy improved hearing in children and adults with ...

Children with hereditary deafness regained their hearing thanks to a type of gene therapy, a new study published on Wednesday found. In a clinical trial, co-led by investigators from Mass Eye and Ear, ...

For those born with certain types of congenital deafness, the cochlear implant has been a positive and enabling technology. It uses electronics to step in as a replacement for the biological ear that ...

Up to three in every 1,000 newborns is born with hearing loss in one or both ears. While cochlear implants have long been a life-changing option, they involve surgery and can't fully replicate the ...

Regeneron's gene therapy DB-OTO shows significant hearing improvements in children with otoferlin-related profound hearing loss, according to trial data. Regeneron Pharmaceuticals has released updated ...

Researchers say deafness can affect children's brain development. Children with hereditary deafness regained their hearing thanks to a type of gene therapy, a new study published on Wednesday found.